Seeking Alpha

Shire (SHPG) will acquire California-based, privately held biopharmaceutical company SARcode...

Shire (SHPG) will acquire California-based, privately held biopharmaceutical company SARcode Bioscience for an upfront payment of $160M plus additional undisclosed payments as certain milestones are met. Shire says the acquisition will strengthen its portfolio by adding a phase 3 compound called LIFITEGRAST indicated for the treatment of dry eye disease. 
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs